2-26474554-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_194248.3(OTOF):​c.3247G>C​(p.Ala1083Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.019 in 1,612,842 control chromosomes in the GnomAD database, including 374 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1083T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.015 ( 20 hom., cov: 31)
Exomes 𝑓: 0.019 ( 354 hom. )

Consequence

OTOF
NM_194248.3 missense

Scores

1
3
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 0.494

Publications

9 publications found
Variant links:
Genes affected
OTOF (HGNC:8515): (otoferlin) Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded protein has 3 C2 domains, a single carboxy-terminal transmembrane domain found also in the C. elegans spermatogenesis factor FER-1 and human dysferlin, while the long form has 6 C2 domains. The homology suggests that this protein may be involved in vesicle membrane fusion. Several transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
OTOF Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005121857).
BP6
Variant 2-26474554-C-G is Benign according to our data. Variant chr2-26474554-C-G is described in ClinVar as Benign. ClinVar VariationId is 21844.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0147 (2245/152340) while in subpopulation NFE AF = 0.0195 (1329/68028). AF 95% confidence interval is 0.0187. There are 20 homozygotes in GnomAd4. There are 1020 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOFNM_194248.3 linkc.3247G>C p.Ala1083Pro missense_variant Exon 26 of 47 ENST00000272371.7 NP_919224.1
OTOFNM_194323.3 linkc.1006G>C p.Ala336Pro missense_variant Exon 9 of 29 ENST00000339598.8 NP_919304.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOFENST00000272371.7 linkc.3247G>C p.Ala1083Pro missense_variant Exon 26 of 47 1 NM_194248.3 ENSP00000272371.2
OTOFENST00000339598.8 linkc.1006G>C p.Ala336Pro missense_variant Exon 9 of 29 1 NM_194323.3 ENSP00000344521.3

Frequencies

GnomAD3 genomes
AF:
0.0147
AC:
2243
AN:
152222
Hom.:
20
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00921
Gnomad AMI
AF:
0.0132
Gnomad AMR
AF:
0.0124
Gnomad ASJ
AF:
0.0231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.0200
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0195
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.0145
AC:
3606
AN:
249378
AF XY:
0.0147
show subpopulations
Gnomad AFR exome
AF:
0.00949
Gnomad AMR exome
AF:
0.00740
Gnomad ASJ exome
AF:
0.0218
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0221
Gnomad NFE exome
AF:
0.0206
Gnomad OTH exome
AF:
0.0156
GnomAD4 exome
AF:
0.0195
AC:
28469
AN:
1460502
Hom.:
354
Cov.:
33
AF XY:
0.0190
AC XY:
13770
AN XY:
726540
show subpopulations
African (AFR)
AF:
0.00884
AC:
296
AN:
33470
American (AMR)
AF:
0.00786
AC:
351
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.0206
AC:
538
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39694
South Asian (SAS)
AF:
0.00321
AC:
277
AN:
86226
European-Finnish (FIN)
AF:
0.0228
AC:
1191
AN:
52338
Middle Eastern (MID)
AF:
0.0106
AC:
61
AN:
5766
European-Non Finnish (NFE)
AF:
0.0222
AC:
24738
AN:
1111832
Other (OTH)
AF:
0.0168
AC:
1016
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
1461
2922
4383
5844
7305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
936
1872
2808
3744
4680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0147
AC:
2245
AN:
152340
Hom.:
20
Cov.:
31
AF XY:
0.0137
AC XY:
1020
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00926
AC:
385
AN:
41580
American (AMR)
AF:
0.0123
AC:
189
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.0231
AC:
80
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00186
AC:
9
AN:
4830
European-Finnish (FIN)
AF:
0.0200
AC:
212
AN:
10622
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0195
AC:
1329
AN:
68028
Other (OTH)
AF:
0.0118
AC:
25
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
107
213
320
426
533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00863
Hom.:
1
Bravo
AF:
0.0143
TwinsUK
AF:
0.0251
AC:
93
ALSPAC
AF:
0.0202
AC:
78
ESP6500AA
AF:
0.0104
AC:
46
ESP6500EA
AF:
0.0233
AC:
200
ExAC
AF:
0.0143
AC:
1735
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.0222
EpiControl
AF:
0.0210

ClinVar

Significance: Benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Aug 31, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 06, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 16371502, 18381613, 20301429) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal recessive nonsyndromic hearing loss 9 Benign:1Other:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

not specified Benign:1
Oct 06, 2010
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ala1083Pro in exon 26 of OTOF: This variant is not expected to have clinical sig nificance because this residue is not highly conserved across species and this v ariant has been reported as benign in two publications (Varga 2006, Rodriguez-Ba llesteros 2008). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.61
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.12
.;.;.;T;.;.
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.11
FATHMM_MKL
Benign
0.34
N
LIST_S2
Uncertain
0.91
D;D;D;D;D;D
MetaRNN
Benign
0.0051
T;T;T;T;T;T
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
0.81
.;.;.;L;L;.
PhyloP100
0.49
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.9
N;N;.;N;N;.
REVEL
Benign
0.045
Sift
Benign
0.27
T;T;.;T;T;.
Sift4G
Benign
0.27
T;T;.;T;T;.
Polyphen
0.28
B;P;.;P;.;P
Vest4
0.29
MPC
0.31
ClinPred
0.0060
T
GERP RS
4.9
Varity_R
0.25
gMVP
0.62
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80356574; hg19: chr2-26697422; COSMIC: COSV55516027; COSMIC: COSV55516027; API